632 related articles for article (PubMed ID: 30917830)
41. Neonatal ventriculosubgaleal shunts.
Fulmer BB; Grabb PA; Oakes WJ; Mapstone TB
Neurosurgery; 2000 Jul; 47(1):80-3; discussion 83-4. PubMed ID: 10917350
[TBL] [Abstract][Full Text] [Related]
42. Whole brain radiotherapy in management of non-small-cell lung carcinoma associated leptomeningeal carcinomatosis: evaluation of prognostic factors.
Ozdemir Y; Yildirim BA; Topkan E
J Neurooncol; 2016 Sep; 129(2):329-35. PubMed ID: 27306442
[TBL] [Abstract][Full Text] [Related]
43. Endoscopic third ventriculostomy: an outcome analysis of primary cases and procedures performed after ventriculoperitoneal shunt malfunction.
O'Brien DF; Javadpour M; Collins DR; Spennato P; Mallucci CL
J Neurosurg; 2005 Nov; 103(5 Suppl):393-400. PubMed ID: 16302610
[TBL] [Abstract][Full Text] [Related]
44. Obstructive hydrocephalus in adult patients: the Louisiana State University Health Sciences Center-Shreveport experience with ventriculoperitoneal shunts.
Reddy GK; Shi R; Nanda A; Guthikonda B
World Neurosurg; 2011; 76(1-2):176-82. PubMed ID: 21839971
[TBL] [Abstract][Full Text] [Related]
45. Management of Hydrocephalus in Children: Anatomic Imaging Appearances of CSF Shunts and Their Complications.
Khalatbari H; Parisi MT
AJR Am J Roentgenol; 2021 Jan; 216(1):187-199. PubMed ID: 33112667
[No Abstract] [Full Text] [Related]
46. Cross-sectional imaging of thoracic and abdominal complications of cerebrospinal fluid shunt catheters.
Bolster F; Fardanesh R; Morgan T; Katz DS; Daly B
Emerg Radiol; 2016 Apr; 23(2):117-25. PubMed ID: 26610766
[TBL] [Abstract][Full Text] [Related]
47. Treatment of cerebrospinal fluid shunting complications in a Nigerian neurosurgery programme. Case illustrations and review.
Komolafe EO; Adeolu AA; Komolafe MA
Pediatr Neurosurg; 2008; 44(1):36-42. PubMed ID: 18097189
[TBL] [Abstract][Full Text] [Related]
48. Surgical management of hydrocephalus secondary to intraventricular hemorrhage in the preterm infant.
Christian EA; Melamed EF; Peck E; Krieger MD; McComb JG
J Neurosurg Pediatr; 2016 Mar; 17(3):278-84. PubMed ID: 26565942
[TBL] [Abstract][Full Text] [Related]
49. Factors associated with early shunt revision within 30 days: analyses from the National Surgical Quality Improvement Program.
Alvi MA; Bhandarkar AR; Daniels DJ; Miller KJ; Ahn ES
J Neurosurg Pediatr; 2022 Jan; 29(1):21-30. PubMed ID: 34624850
[TBL] [Abstract][Full Text] [Related]
50. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients.
Ritz R; Roser F; Morgalla M; Dietz K; Tatagiba M; Will BE
BMC Infect Dis; 2007 May; 7():38. PubMed ID: 17488498
[TBL] [Abstract][Full Text] [Related]
51. Ultrasound guided placement of the distal catheter in paediatric ventriculoatrial shunts-an appraisal of efficacy and complications.
Clark DJ; Chakraborty A; Roebuck DJ; Thompson DN
Childs Nerv Syst; 2016 Jul; 32(7):1219-25. PubMed ID: 27207611
[TBL] [Abstract][Full Text] [Related]
52. Parent/guardian knowledge regarding implanted shunt type, setting, and symptoms of malfunction/infection.
Ackerman LL; Fulkerson DH; Jea A; Smith JL
J Neurosurg Pediatr; 2018 Apr; 21(4):359-366. PubMed ID: 29328006
[TBL] [Abstract][Full Text] [Related]
53. Our initial experience with ventriculo-epiplooic shunt in treatment of hydrocephalus in two centers.
Grigorean VT; Sandu AM; Popescu M; Florian IS; Lupascu CD; Ursulescu CL
Neurol Neurochir Pol; 2017; 51(4):290-298. PubMed ID: 28528738
[TBL] [Abstract][Full Text] [Related]
54. Prior CSF shunting increases the risk of endoscopic third ventriculostomy failure in the treatment of obstructive hydrocephalus in adults.
Woodworth G; McGirt MJ; Thomas G; Williams MA; Rigamonti D
Neurol Res; 2007 Jan; 29(1):27-31. PubMed ID: 17427271
[TBL] [Abstract][Full Text] [Related]
55. Diverse clinical applications of percutaneous lumboperitoneal shunts.
James HE; Tibbs PA
Neurosurgery; 1981 Jan; 8(1):39-42. PubMed ID: 7207771
[TBL] [Abstract][Full Text] [Related]
56. Leptomeningeal carcinomatosis originating from advanced gastric cancer--a report of three cases and review of the literatures.
Kusumoto T; Kimura Y; Sugiyama M; Ohta M; Tsutsumi N; Sakaguchi Y; Ikejiri K; Oki E; Saeki H; Morita M; Ikeda T; Furuta T; Maehara Y
Fukuoka Igaku Zasshi; 2013 Nov; 104(11):456-63. PubMed ID: 24620642
[TBL] [Abstract][Full Text] [Related]
57. Ascites following ventriculoperitoneal shunting in children with chiasmatic-hypothalamic glioma.
Gil Z; Beni-Adani L; Siomin V; Nagar H; Dvir R; Constantini S
Childs Nerv Syst; 2001 Jun; 17(7):395-8. PubMed ID: 11465792
[TBL] [Abstract][Full Text] [Related]
58. Childhood optic pathway tumors associated with ascites following ventriculoperitoneal shunt placement.
West GA; Berger MS; Geyer JR
Pediatr Neurosurg; 1994; 21(4):254-8; discussion 259. PubMed ID: 7865412
[TBL] [Abstract][Full Text] [Related]
59. Rate of shunt revision as a function of age in patients with shunted hydrocephalus due to myelomeningocele.
Dupepe EB; Hopson B; Johnston JM; Rozzelle CJ; Jerry Oakes W; Blount JP; Rocque BG
Neurosurg Focus; 2016 Nov; 41(5):E6. PubMed ID: 27798984
[TBL] [Abstract][Full Text] [Related]
60. The Preventable Shunt Revision Rate: a potential quality metric for pediatric shunt surgery.
Venable GT; Rossi NB; Morgan Jones G; Khan NR; Smalley ZS; Roberts ML; Klimo P
J Neurosurg Pediatr; 2016 Jul; 18(1):7-15. PubMed ID: 26966884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
